Institute of Animal Science, Volcani Center - ARO, Rishon LeZion, Israel.
Department of Animal Science, The Hebrew University of Jerusalem, Rehovot, Israel.
Sci Rep. 2020 Jul 22;10(1):12189. doi: 10.1038/s41598-020-68909-z.
Hepatic steatosis is strongly associated with chronic liver disease and systemic metabolic disorder. Adipose lipolysis is a recognized principal source of intrahepatic fat in various metabolic disorders, including non-alcoholic fatty liver disease. We hypothesized that, in the premorbid state, hepatic de novo lipogenesis (DNL) driven by excess carbohydrates abundance might play a more significant role. We employed a novel nutritional model in sheep of two distinct carbohydrates abundances. During 4 months of the dietary treatment, lambs were monitored for metabolic and terminal liver parameters. Lambs grown on the high-calorie (HC) diet were consistently more hyperglycemic and hyperinsulinemic than lambs grown on the lower-calorie (LC) diet (P < 0.0001). As a result, the HC lambs developed systemic- (HOMA-IR of 7.3 vs. 3.1; P < 0.0001), and adipose- (ADIPO-IR of 342.7 vs. 74.4; P < 0.0001) insulin resistance, significant adiposity (P < 0.0001), and higher plasma triglycerides (P < 0.05). Circulating leukocytes in the HC lambs had higher mRNA expression levels of the proinflammatory markers CCL2 (P < 0.01) and TNF-alpha (P < 0.04), and IL1B trended higher (P < 0.1). Remarkably, lambs on the HC diet developed substantial liver steatosis (mean fat content of 8.1 vs. 5.3% in the LC group; P < 0.0001) with a higher histological steatosis score (2.1 vs. 0.4; P < 0.0002). Hepatic steatosis was most-strongly associated with blood glucose and insulin levels but negatively correlated with circulating fatty acids-indicating a more significant contribution from hepatic DNL than from adipose lipolysis. Sheep may prove an attractive large-animal model of fatty liver and metabolic comorbidities resulting from excess carbohydrate-based energy early in life.
肝脂肪变性与慢性肝病和全身代谢紊乱密切相关。脂肪分解是各种代谢紊乱中肝内脂肪的公认主要来源,包括非酒精性脂肪肝疾病。我们假设,在疾病前期,由过量碳水化合物丰度驱动的肝从头脂肪生成(DNL)可能发挥更重要的作用。我们在绵羊中采用了一种新的营养模型,该模型具有两种不同的碳水化合物丰度。在饮食治疗的 4 个月期间,监测羔羊的代谢和终末肝脏参数。与低热量(LC)饮食组相比,高热量(HC)饮食组的羔羊持续表现出更高的血糖和胰岛素水平(P<0.0001)。结果,HC 组羔羊发展为全身胰岛素抵抗(HOMA-IR 为 7.3 对 3.1;P<0.0001)和脂肪组织胰岛素抵抗(ADIPO-IR 为 342.7 对 74.4;P<0.0001),显著肥胖(P<0.0001)和更高的血浆甘油三酯(P<0.05)。HC 组羔羊循环白细胞中促炎标志物 CCL2(P<0.01)和 TNF-alpha(P<0.04)的 mRNA 表达水平更高,IL1B 呈上升趋势(P<0.1)。值得注意的是,HC 饮食组的羔羊发生了大量的肝脂肪变性(脂肪含量均值为 8.1%对 LC 组的 5.3%;P<0.0001),且组织学脂肪变性评分更高(2.1 对 0.4;P<0.0002)。肝脂肪变性与血糖和胰岛素水平密切相关,但与循环脂肪酸呈负相关,这表明肝 DNL 的贡献比脂肪组织脂肪分解更为显著。绵羊可能被证明是一种有吸引力的大型动物模型,可用于研究生命早期过量基于碳水化合物的能量导致的脂肪肝和代谢合并症。